Biogen Idec (BIIB) Said FDA Extends PDUFA Date for BG-12 3 Months
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Elan (ELN), Novartis (NVS) Tick Higher on PDUFA Extension for Biogen's (BIIB) MS PillBG-12
October 18, 2012 8:45 AM EDTElan Corp. (NYSE: ELN) and Novartis (NYSE: NVS) shares are ticking higher following the FDA extending the initial PDUFA date for its review of the New Drug Application (NDA) for the marketing approval of Biogen Idec's (Nasdaq:... More
